You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

macrophage

Showing 1 - 25 of 1,807
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

Recruiting
  • Cardiac Sarcoidosis
  • 64Cu-DOTATATE PET/CT scan
  • Copenhagen, Denmark
    Rigshospitalet
Nov 14, 2023

RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

Recruiting
  • Cervical
    • Wuxi, Jiangsu, China
      Wuxi People's Hospital
    Jul 3, 2023

    EVALUATION OF MACROPHAGE INFLAMMATORY PROTEIN-1a AS A

    Not yet recruiting
    • Periodontitis Chronic Generalized Severe
    • +2 more
      • Rohtak, Haryana, India
        Post Graduate Institute of Dental Sciences
      Aug 23, 2023

      SARS-CoV-2 Pneumonia Trial in Durham (Ozone)

      Not yet recruiting
      • SARS-CoV-2 Pneumonia
      • Durham, North Carolina
        Duke University Medical Center
      Mar 3, 2023

      Dietary Protein Trial in Saint Louis (Dietary protein shake)

      Active, not recruiting
      • Dietary Protein
      • Dietary protein shake
      • Saint Louis, Missouri
        Washington University
      Jan 29, 2023

      Neuroblastoma Trial (Naxitamab)

      Not yet recruiting
      • Neuroblastoma
      • (no location specified)
      Sep 18, 2023

      Acute Respiratory Distress Syndrome, Ventilator Associated Pneumonia Trial in Denver (Non-Bronchoscopic Mini Bronchoalveolar

      Recruiting
      • Acute Respiratory Distress Syndrome
      • Ventilator Associated Pneumonia
      • Non-Bronchoscopic Mini Bronchoalveolar Lavage
      • Denver, Colorado
        Intermountain Health - St. Joseph's Hospital - National Jewish H
      Mar 2, 2023

      Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)

      Not yet recruiting
      • Macrophage Activation Syndrome
      • (no location specified)
      Mar 16, 2022

      Breast Cancer Trial in Toulouse (Patients with breast cancer (stage I, II III or IV))

      Completed
      • Breast Cancer
      • Patients with breast cancer (stage I, II III or IV)
      • Toulouse, France
        Institut Universitaire du Cancer de Toulouse - Oncopole
      Sep 27, 2022

      Healthy Volunteer Trial (SPR720)

      Not yet recruiting
      • Healthy Volunteer
      • (no location specified)
      Jul 13, 2023

      Macrophage Function

      Enrolling by invitation
      • Polymorphism
      • Lung Inflammation
        • Research Triangle Park, North Carolina
          NIEHS, Research Triangle Park
        Jul 6, 2022

        Leiomyosarcoma Trial in Toulouse (Blood samples will be collected at different times.)

        Not yet recruiting
        • Leiomyosarcoma
        • Blood samples will be collected at different times.
        • Toulouse, France
          Institut Universitaire du Cancer Toulouse - Oncopole
        Aug 2, 2022

        Air Pollution Trial in Piscataway (Clean Air, Ozone)

        Recruiting
        • Air Pollution
        • Clean Air
        • Ozone
        • Piscataway, New Jersey
          Rutgers - EOHSI
        Mar 20, 2023

        Macrophage Activation Syndrome Trial in Birmingham (kineret, )

        Active, not recruiting
        • Macrophage Activation Syndrome
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Dec 13, 2021

        Toxicities in Children and Adults With Cancer

        Active, not recruiting
        • Macrophage Activation Syndrome
        • Primary Hemophagocytic Lymphohistiocytosis
          • Bethesda, Maryland
            National Cancer Institute (NCI)
          Sep 17, 2022

          ARDS Trial in Nanjing

          Recruiting
          • ARDS
            • Nanjing, Jiangsu, China
              Nanjing Zhong-Da Hospital, Southeast University
            Jul 17, 2022

            Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

            Recruiting
            • Neuroblastoma
            • Naxitamab monotherapy
            • +6 more
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Aug 31, 2023

            DIABETES, MYOCARD INFARCTUS Trial in Nice (blood sample)

            Completed
            • DIABETES
            • MYOCARD INFARCTUS
            • blood sample
            • Nice, France
              CHU de Nice
            May 13, 2022

            Diabetes, Gastroparesis With Diabetes Trial in Rochester (PET/CT Scan with 11C-ER176, Core biopsy of gastric muscle)

            Active, not recruiting
            • Diabetes
            • Gastroparesis With Diabetes Mellitus
            • PET/CT Scan with 11C-ER176
            • Core biopsy of gastric muscle
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Apr 11, 2022

            Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

            Recruiting
            • Neuroblastoma Recurrent
            • Natural killer cell
            • +4 more
            • Hong Kong, Hong Kong
              Hong Kong Children's Hospital
            Feb 22, 2023

            Macrophage-mediated Inflammation in White Adipose Tissue and

            Suspended
            • Non-Alcoholic Fatty Liver Disease
              • London, United Kingdom
                Imperial College NHS Trust
              Mar 24, 2022

              Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

              Completed
              Has Results
              • Macrophage Activation Syndrome
              • +3 more
              • Cincinnati, Ohio
              • +4 more
              May 16, 2022

              Systemic Lupus Erythematosus Trial (Macrophage migration inhibitory factor)

              Not yet recruiting
              • Systemic Lupus Erythematosus
              • Macrophage migration inhibitory factor
              • (no location specified)
              Feb 13, 2022

              Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

              Recruiting
              • Recurrent Osteosarcoma
              • humanized anti-GD2 antibody
              • GM-CSF
              • Los Angeles, California
              • +2 more
              Dec 22, 2022

              Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)

              Active, not recruiting
              • Neuroblastoma
              • Hu3F8 With GM-CSF
              • New York, New York
                Memorial Sloan Kettering Cancer Center
              May 2, 2022